Transcranial Alternating Current Stimulation Clinical Trials
2 recruiting trials for Transcranial Alternating Current Stimulation. Eligibility criteria explained in plain English.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease
To investigate the clinical effect neural mechanism of transcranial alternating current stimulation in early Alzheimer's disease
Efficacy of Hi-tACS for Schizophrenia Negative Symptoms
The goal of this clinical trial is to investigate whether Hi-tACS is effective and safe in treating negative symptoms of schizophrenia. Schizophrenic patients will receive...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Transcranial Alternating Current Stimulation, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Transcranial Alternating Current Stimulation, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Transcranial Alternating Current Stimulation, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.